Riverview Capital Advisers’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Riverview Capital Advisers's JNJ Position: Q1 2026 in Review
Riverview Capital Advisers reduced its Johnson & Johnson (JNJ) stake by 59% in Q1 2026, selling an estimated $983K and leaving 2,950 shares worth $721K. The position accounts for 0.24% of the portfolio, ranked #50.
Riverview Capital Advisers first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.48M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Riverview Capital Advisers held 2,950 shares of Johnson & Johnson worth $721K as of Q1 2026.
- Riverview Capital Advisers sold 4,221 Johnson & Johnson shares in Q1 2026, an estimated $983K.
- Johnson & Johnson made up 0.24% of Riverview Capital Advisers's portfolio in Q1 2026, its #50 holding.
- Riverview Capital Advisers first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
- Riverview Capital Advisers's Johnson & Johnson position peaked at $1.48M in Q4 2025.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Riverview Capital Advisers's 13F filing for Q1 2026, filed 14 May 2026.